Completed NA INTERVENTIONAL 3-arm NCT04764604

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

Evaluating the Therapeutic Use of a Vibratory Positive Expiratory Pressure Device (Acapella® Choice) in the Treatment of Pathological Voice - A Feasibility Study

Sponsor: Smiths Medical, ASD, Inc.

Conditions Dysphonia Muscle Tension Dysphonia Presbylarynx Vocal Cord Paralysis Vocal Fold Palsy

Interventions Acapella Choice Tube-in-water

Updated 5 times since 2021 Last updated: Jul 10, 2023 Started: Dec 14, 2020 Primary completion: Nov 29, 2021 Completion: Nov 29, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Dysphonia and Muscle Tension Dysphonia, this trial is completed. The trial is conducted by Smiths Medical, ASD, Inc. and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Jun 2022 — Sep 2023 [monthly]

Completed NA

Status: Recruiting → Completed
Mar 2021 — Jun 2022 [monthly]

Recruiting NA

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Smiths Medical, ASD, Inc.
University College, London

Data source: University College, London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom